Loading provider…
Loading provider…
Specialist in New York, NY
NPI: 1457314973Primary Practice Location
HOSPITAL FOR SPECIAL SURGERY
535 E 70th St, New York, NY
Primary Employer
Hospital for Special Surgery
hss.edu
HQ Phone
Get M.D. Kyriakos's Phone Numberphone_androidMobile
Get M.D. Kyriakos's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
2021
NJ State Medical License
1999 - 2027
NY State Medical License
2003 - 2026
CT State Medical License
2021 - 2025
NY State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Rheumatology
New York Presbyterian Hospital (Cornell Campus)
Fellowship • Rheumatology
1995 - 1998
New York-Presbyterian/Queens
Residency • Internal Medicine
1992 - 1995
Aristotle University of Thessaloniki School of Medicine
Medical School
Until 1988
Targeting of Type I Interferon in Systemic Autoimmune Diseases
Authors: Crow, Mary K, Olferiev, Mikhail, Kirou, Kyriakos A
Journal: Transl Res
Publication Date: 2014-10-16
Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment.
Hydroxychloroquine and lupus flare: a good drug, but we need to do better.
Authors: Crow, Mary K, Kirou, Kyriakos A
Journal: Ann Rheum Dis
Publication Date: 2022-01-17
Lead Sponsor: Ampel BioSolutions, LLC
Intervention / Treatment: OTHER: Decision Support Test
Lead Sponsor: State University of New York - Upstate Medical University
Collaborators: Cedars-Sinai Medical Center, University of Rochester, Yale University, Penn State University, Hospital for Special Surgery, New York, Ohio State University, St. Luke's Hospital and Health Network, Pennsylvania, Oklahoma City VA Health Care System
Intervention / Treatment: DRUG: Placebo, DRUG: N-acetylcysteine
Lead Sponsor: Northwell Health
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Intervention / Treatment: DRUG: Nelfinavir